Sat Mar 23, 2024 11:33 pm by globalturbo
Another Study Identifies High Rate of Severe Myocarditis Post COVID Vax
Posted on June 30, 2023
(Kateryna Kon/Shutterstock)
Ray Arora
Cardiologist Dr. Anish Koka weighs in: “This should hopefully end the mainstream expert narrative characterizing vaccine myocarditis as mild.”
The academic publication in the European Heart Journal can be found here.
[…]
Myocardial inflammation linked to the mRNA vaccines has become a bizarrely contentious and politicized topic. Never before has there been a time in history where one’s political orientation could predict their views on the safety of a drug or therapeutic. The psychopathic media witch-burning of Joe Rogan for his views on vaccine myocarditis and child vaccination informed by Dr. Tracy Beth Hoeg and Dr. Mandrola’s paper in 2021 was the most telling example that this conversation had been corrupted by forces powerful enough to obscure the data.
This new study published in the European Heart Journal is incredibly comprehensive. In South Korea, the Korean Disease Control and Prevention Agency (KDCA) established a reporting system to make it legally obligatory to report vaccine adverse events such as myocarditis.
Among 44,276,704 South Koreans vaccinated, 1,533 cases of suspected myocarditis were identified under the KDCA. Of the 1,533 total cases, the KDCA’s “Expert Adjudication Committee on COVID-19 Vaccination Pericarditis/Myocarditis” confirmed 480 cases. The population-wide risk comes to 1 in 100,000.
For teenage boys ages 12–17, where the risk is most concentrated, the vaccine myocarditis incidence was predictably far higher at 1 in 18,900. This reported rate is far lower than other estimates from Hong Kong’s active surveillance system (1 in 2,680 after dose two) and Kaiser Permanente (1 in 2,650 after dose two) in the same age group. While a 1 in 18,000 risk is nontrivial on a population level, several reasons explain why South Korean researchers found a lower rate of myocarditis than various other American, European, and Asian study estimates.
Most importantly, of the vaccinated South Korean population in the study, less than three-quarters took the mRNA jabs (71 percent), of which 56 percent took the Pfizer shots. Only 15 percent of vaccinees took the Moderna shots. This is noteworthy because vaccine-induced myocarditis incidence is far higher in those vaccinated with the Moderna product. The same link has not been robustly identified in non-mRNA COVID-19 vaccines. Almost a third of vaccinated South Koreans took a non-mRNA vaccine (AstraZeneca and the Johnson & Johnson vaccine).
Secondly, the study did not tally myocarditis rates by vaccine dose for different age groups in men and women. The second dose of the vaccine is known to cause higher rates of myocarditis in young men than the first. In other words, a more careful breakdown by dose and vaccine type would have revealed a far higher incidence of vaccine myocarditis. The researchers did, however, compare myocarditis incidence across vaccine doses broadly (without breaking it down by age and gender, as mentioned):
Predictably, Moderna dose two is associated with the highest rate of 1 in 86,000. Pfizer is the second most dangerous vaccine in this regard, with an incidence of 1 in 166,600 per vaccinated persons after the second dose. Comparatively, the AstraZeneca vaccine is associated with a 1 in 1,111,111 incidence of vaccine-related myocarditis.
Unsurprisingly, this study shows the mRNAs are far more dangerous (at least on the myocarditis front) than other COVID-19 vaccines.
Another reason why researchers identified a lower incidence of myocarditis is the methodology used for the adjudication of myocarditis cases. According to cardiologist Dr. Anish Koka, who provided his comments on this study, “This also reflects more stringent criteria used by Korean investigators in diagnosing vaccine myocarditis.”
As Koka further explained, “The committee rejected the level 3 BC case definition of myocarditis and the level 2 BC case definition that did not have associated cardiac damage evident on a blood test or any case with a positive result for COVID-19 infection.” As a result, many probable and likely cases of vaccine myocarditis were excluded due to highly stringent criteria.
Note: The rates of subclinical myocarditis still remain unknown and can’t be captured in a study like this. Based on one small Thai study, we have reason to believe many young men have suffered from subclinical myocarditis by the mRNA shots, to varying degrees, but have not been tracked by public health agencies.
The most concerning part of the study is the reported rate of “severe Covid-19 vaccine-related myocarditis.” Researchers identified 95 cases (19.8 percent) of severe myocarditis, 85 ICU admissions (17.7 percent), 36 fulminant myocarditis cases (7.5 percent), 21 ECMO [extracorporeal membrane oxygenation] therapies—a modified heart-lung by-pass machine—(4.4 percent), 21 deaths (4.4 percent), and one heart transplantation (0.2 percent).
Koka views a 20 percent rate of serious complications from vaccine-related myocarditis as “startling.”
[…]
Via https://www.theepochtimes.com/health/another-study-identifies-high-rate-of-severe-myocarditis-cases-post-covid-vax_5330449.html
THANKS TO: https://stuartbramhall.wordpress.com/2023/06/30/another-study-identifies-high-rate-of-severe-myocarditis-post-covid-vax/
Posted on June 30, 2023
(Kateryna Kon/Shutterstock)
Ray Arora
Cardiologist Dr. Anish Koka weighs in: “This should hopefully end the mainstream expert narrative characterizing vaccine myocarditis as mild.”
The academic publication in the European Heart Journal can be found here.
[…]
New South Korean Study Identifies High Rate of Severe Myocarditis Cases
A new South Korean nationwide study on vaccine-related myocarditis contains troubling implications on the severity of cardiac damage conferred by the mass experiment conducted on the population—young men in particular—without informed consent and a clear understanding of risk-reward ratios.Myocardial inflammation linked to the mRNA vaccines has become a bizarrely contentious and politicized topic. Never before has there been a time in history where one’s political orientation could predict their views on the safety of a drug or therapeutic. The psychopathic media witch-burning of Joe Rogan for his views on vaccine myocarditis and child vaccination informed by Dr. Tracy Beth Hoeg and Dr. Mandrola’s paper in 2021 was the most telling example that this conversation had been corrupted by forces powerful enough to obscure the data.
This new study published in the European Heart Journal is incredibly comprehensive. In South Korea, the Korean Disease Control and Prevention Agency (KDCA) established a reporting system to make it legally obligatory to report vaccine adverse events such as myocarditis.
Among 44,276,704 South Koreans vaccinated, 1,533 cases of suspected myocarditis were identified under the KDCA. Of the 1,533 total cases, the KDCA’s “Expert Adjudication Committee on COVID-19 Vaccination Pericarditis/Myocarditis” confirmed 480 cases. The population-wide risk comes to 1 in 100,000.
For teenage boys ages 12–17, where the risk is most concentrated, the vaccine myocarditis incidence was predictably far higher at 1 in 18,900. This reported rate is far lower than other estimates from Hong Kong’s active surveillance system (1 in 2,680 after dose two) and Kaiser Permanente (1 in 2,650 after dose two) in the same age group. While a 1 in 18,000 risk is nontrivial on a population level, several reasons explain why South Korean researchers found a lower rate of myocarditis than various other American, European, and Asian study estimates.
Most importantly, of the vaccinated South Korean population in the study, less than three-quarters took the mRNA jabs (71 percent), of which 56 percent took the Pfizer shots. Only 15 percent of vaccinees took the Moderna shots. This is noteworthy because vaccine-induced myocarditis incidence is far higher in those vaccinated with the Moderna product. The same link has not been robustly identified in non-mRNA COVID-19 vaccines. Almost a third of vaccinated South Koreans took a non-mRNA vaccine (AstraZeneca and the Johnson & Johnson vaccine).
Secondly, the study did not tally myocarditis rates by vaccine dose for different age groups in men and women. The second dose of the vaccine is known to cause higher rates of myocarditis in young men than the first. In other words, a more careful breakdown by dose and vaccine type would have revealed a far higher incidence of vaccine myocarditis. The researchers did, however, compare myocarditis incidence across vaccine doses broadly (without breaking it down by age and gender, as mentioned):
Predictably, Moderna dose two is associated with the highest rate of 1 in 86,000. Pfizer is the second most dangerous vaccine in this regard, with an incidence of 1 in 166,600 per vaccinated persons after the second dose. Comparatively, the AstraZeneca vaccine is associated with a 1 in 1,111,111 incidence of vaccine-related myocarditis.
Unsurprisingly, this study shows the mRNAs are far more dangerous (at least on the myocarditis front) than other COVID-19 vaccines.
Another reason why researchers identified a lower incidence of myocarditis is the methodology used for the adjudication of myocarditis cases. According to cardiologist Dr. Anish Koka, who provided his comments on this study, “This also reflects more stringent criteria used by Korean investigators in diagnosing vaccine myocarditis.”
As Koka further explained, “The committee rejected the level 3 BC case definition of myocarditis and the level 2 BC case definition that did not have associated cardiac damage evident on a blood test or any case with a positive result for COVID-19 infection.” As a result, many probable and likely cases of vaccine myocarditis were excluded due to highly stringent criteria.
Note: The rates of subclinical myocarditis still remain unknown and can’t be captured in a study like this. Based on one small Thai study, we have reason to believe many young men have suffered from subclinical myocarditis by the mRNA shots, to varying degrees, but have not been tracked by public health agencies.
The most concerning part of the study is the reported rate of “severe Covid-19 vaccine-related myocarditis.” Researchers identified 95 cases (19.8 percent) of severe myocarditis, 85 ICU admissions (17.7 percent), 36 fulminant myocarditis cases (7.5 percent), 21 ECMO [extracorporeal membrane oxygenation] therapies—a modified heart-lung by-pass machine—(4.4 percent), 21 deaths (4.4 percent), and one heart transplantation (0.2 percent).
Koka views a 20 percent rate of serious complications from vaccine-related myocarditis as “startling.”
[…]
Via https://www.theepochtimes.com/health/another-study-identifies-high-rate-of-severe-myocarditis-cases-post-covid-vax_5330449.html
THANKS TO: https://stuartbramhall.wordpress.com/2023/06/30/another-study-identifies-high-rate-of-severe-myocarditis-post-covid-vax/
